Literature DB >> 3757766

Comparison of intravenously administered methadone, morphine and heroin.

D R Jasinski, K L Preston.   

Abstract

Data from previously reported studies suggest that methadone may be more euphorigenic than other morphine-like drugs. To determine whether methadone is more potent in producing euphoria relative to its other opiate-like effects, single doses of intravenously administered methadone, morphine, heroin and placebo were compared in non-dependent post-addict volunteers. Morphine-like physiologic, subjective and behavioral effects were measured periodically for 24 h after drug administration. Under the conditions of the experiment methadone produced a profile of effects which was indistinguishable from that of morphine and heroin. Only the time course of miosis, which was longer lasting following methadone, differentiated among the three compounds. The relative potencies of methadone, morphine and heroin for the initial 5 h of effect were constant over all opiate-like effects, including measures of euphoria. Thus, methadone was not a selective euphoriant.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3757766     DOI: 10.1016/0376-8716(86)90079-7

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  11 in total

1.  Harm reduction in Bern: from outreach to heroin maintenance.

Authors:  R B Haemmig
Journal:  Bull N Y Acad Med       Date:  1995

Review 2.  Heroin maintenance for chronic heroin-dependent individuals.

Authors:  Marica Ferri; Marina Davoli; Carlo A Perucci
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

3.  Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course.

Authors:  George E Bigelow; Kenzie L Preston; John Schmittner; Qunming Dong; David R Gastfriend
Journal:  Drug Alcohol Depend       Date:  2011-11-12       Impact factor: 4.492

4.  Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.

Authors:  Ning-Sheng Cai; César Quiroz; Jordi Bonaventura; Alessandro Bonifazi; Thomas O Cole; Julia Purks; Amy S Billing; Ebonie Massey; Michael Wagner; Eric D Wish; Xavier Guitart; William Rea; Sherry Lam; Estefanía Moreno; Verònica Casadó-Anguera; Aaron D Greenblatt; Arthur E Jacobson; Kenner C Rice; Vicent Casadó; Amy H Newman; John W Winkelman; Michael Michaelides; Eric Weintraub; Nora D Volkow; Annabelle M Belcher; Sergi Ferré
Journal:  J Clin Invest       Date:  2019-03-26       Impact factor: 14.808

5.  Heroin-using drivers: importance of morphine and morphine-6-glucuronide on late clinical impairment.

Authors:  Liliana Bachs; Gudrun Høiseth; Svetlana Skurtveit; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2006-10-05       Impact factor: 2.953

Review 6.  Developing a vaccine against multiple psychoactive targets: a case study of heroin.

Authors:  G Neilm Stowe; Joel E Schlosburg; Leandro F Vendruscolo; Scott Edwards; Kaushik K Misra; Gery Schulteis; Joseph S Zakhari; George F Koob; Kim D Janda
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

Review 7.  Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.

Authors:  Chloe J Jordan; Jianjing Cao; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2019-04-19       Impact factor: 5.250

8.  Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies.

Authors:  William W Stoops; Kevin W Hatton; Michelle R Lofwall; Paul A Nuzzo; Sharon L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2010-07-28       Impact factor: 4.530

9.  Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history.

Authors:  J L Azolosa; M L Stitzer; M K Greenwald
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

10.  Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers.

Authors:  Sandra D Comer; Maria A Sullivan; Robert A Whittington; Suzanne K Vosburg; William J Kowalczyk
Journal:  Neuropsychopharmacology       Date:  2007-06-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.